WMSA
FATE icon

Weiss Multi-Strategy Advisers’s Fate Therapeutics FATE Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,831
Closed -$517K – 696
2021
Q4 		$517K Sell
8,831
-38
-0.4% -$2.15K 0.01% 548
2021
Q3 		$526K Sell
8,869
-2,131
-19% -$167K 0.01% 550
2021
Q2 		$955K Sell
11,000
-1,028
-9% -$82.8K 0.02% 498
2021
Q1 		$992K Sell
12,028
-2,972
-20% -$285K 0.02% 482
2020
Q4 		$1.36M Sell
15,000
-5,224
-26% -$324K 0.03% 461
2020
Q3 		$808K Buy
20,224
+224
+1% +$7.82K 0.02% 445
2020
Q2 		$686K Buy
20,000
+10,370
+108% +$309K 0.02% 447
2020
Q1 		$214K Sell
9,630
-370
-4% -$9.36K 0.01% 385
2019
Q4 		$196K Sell
10,000
-10,000
-50% -$159K ﹤0.01% 572
2019
Q3 		$311K Hold
20,000
– – 0.01% 521
2019
Q2 		$406K Sell
20,000
-3,500
-15% -$63.1K 0.01% 437
2019
Q1 		$413K Buy
23,500
+279
+1% +$4.4K 0.01% 448
2018
Q4 		$298K Sell
23,221
-6,779
-23% -$94.5K 0.01% 388
2018
Q3 		$489K Buy
+30,000
New +$355K 0.01% 446

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Weiss Multi-Strategy Advisers's FATE Position: Q1 2022 in Review

Weiss Multi-Strategy Advisers sold out of Fate Therapeutics (FATE) in Q1 2022, closing a stake of 8,831 shares — an estimated $517K sold.

Weiss Multi-Strategy Advisers first reported a position in FATE in Q3 2018 and held it in 14 quarters. The position peaked at $1.36M in Q4 2020. 250 funds tracked by Wall St. Rank hold FATE as of Q1 2022.

  • Weiss Multi-Strategy Advisers reported no remaining Fate Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 8,831 Fate Therapeutics shares in Q1 2022, an estimated $517K.
  • Weiss Multi-Strategy Advisers first reported a position in Fate Therapeutics in Q3 2018 and held it in 14 quarters.
  • Weiss Multi-Strategy Advisers's Fate Therapeutics position peaked at $1.36M in Q4 2020.
  • 250 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2022, filed 16 May 2022.